Financhill
Back

Brainstorm Cell Therapeutics Vs. Theriva Biologics Industry Stock Comparison

Sell
47

BCLI
Brainstorm Cell Therapeutics

Last Price:
0.51
Seasonality Move:
13.93%
Sell
32

TOVX
Theriva Biologics

Last Price:
0.38
Seasonality Move:
-6.11%
Sell
47
Brainstorm Cell Therapeutics (BCLI) is a Sell

Is Brainstorm Cell Therapeutics a Buy, Sell or Hold?

  • The current Brainstorm Cell Therapeutics [BCLI] share price is $0.52. The Score for BCLI is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • BCLI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
Theriva Biologics (TOVX) is a Sell

Is Theriva Biologics a Buy, Sell or Hold?

  • The current Theriva Biologics [TOVX] share price is $0.37. The Score for TOVX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • TOVX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BCLI Stock Price Chart

What is Brainstorm Cell Therapeutics's stock price today?

  • The Brainstorm Cell Therapeutics share price today is $0.52
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BCLI is experiencing slight buying pressure.

TOVX Stock Price Chart

What is Theriva Biologics's stock price today?

  • The Theriva Biologics share price today is $0.37
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TOVX is experiencing slight selling pressure.

BCLI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 53.54 Buy
Chaikin Money Flow: -33907 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.42 - 0.54) Buy
Bollinger Bands (100): (0.3 - 0.54) Buy

TOVX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 39.42 Sell
Chaikin Money Flow: -4891 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.38 - 0.42) Sell
Bollinger Bands (100): (0.41 - 0.49) Sell

BCLI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.49 Buy
20-day SMA: 0.47 Buy
50-day SMA: 0.51 Buy
200-day SMA: 0.54 Sell
8-day EMA: 0.49 Buy
20-day EMA: 0.49 Buy
50-day EMA: 0.48 Buy
200-day EMA: 0.73 Sell

TOVX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.38 Sell
20-day SMA: 0.4 Sell
50-day SMA: 0.43 Sell
200-day SMA: 0.48 Sell
8-day EMA: 0.38 Sell
20-day EMA: 0.4 Sell
50-day EMA: 0.42 Sell
200-day EMA: 0.53 Sell

Brainstorm Cell Therapeutics Earnings Growth & BCLI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and a decrease next year of $0.05 per share.

Theriva Biologics Earnings Growth & TOVX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and an increase next year of $0.05 per share.

Brainstorm Cell Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Theriva Biologics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):